Genomic Mining Limited - Period Ending 2017-03-31

Genomic Mining Limited - Period Ending 2017-03-31


Genomic Mining Limited NI039951 true 2016-04-01 2017-03-31 2017-03-31 The principal activity of the company is dormant company Digita Accounts Production Advanced 6.18.8247.0 Software true Dr Paul Harkin Dr Paul Harkin NI039951 2016-04-01 2017-03-31 NI039951 2017-03-31 NI039951 bus:OrdinaryShareClass1 2017-03-31 NI039951 bus:OrdinaryShareClass2 2017-03-31 NI039951 bus:PreferenceShareClass1 2017-03-31 NI039951 core:RetainedEarningsAccumulatedLosses 2017-03-31 NI039951 core:ShareCapital 2017-03-31 NI039951 core:CurrentFinancialInstruments 2017-03-31 NI039951 core:CurrentFinancialInstruments core:WithinOneYear 2017-03-31 NI039951 bus:FRS102 2016-04-01 2017-03-31 NI039951 bus:AuditExempt-NoAccountantsReport 2016-04-01 2017-03-31 NI039951 bus:FullAccounts 2016-04-01 2017-03-31 NI039951 bus:RegisteredOffice 2016-04-01 2017-03-31 NI039951 bus:Director2 2016-04-01 2017-03-31 NI039951 bus:Director3 2016-04-01 2017-03-31 NI039951 bus:OrdinaryShareClass1 2016-04-01 2017-03-31 NI039951 bus:OrdinaryShareClass2 2016-04-01 2017-03-31 NI039951 bus:PreferenceShareClass1 2016-04-01 2017-03-31 NI039951 bus:PrivateLimitedCompanyLtd 2016-04-01 2017-03-31 NI039951 countries:NorthernIreland 2016-04-01 2017-03-31 NI039951 2015-04-01 2016-03-31 NI039951 2016-03-31 NI039951 bus:OrdinaryShareClass1 2016-03-31 NI039951 bus:OrdinaryShareClass2 2016-03-31 NI039951 bus:PreferenceShareClass1 2016-03-31 NI039951 core:RetainedEarningsAccumulatedLosses 2016-03-31 NI039951 core:ShareCapital 2016-03-31 NI039951 core:CurrentFinancialInstruments 2016-03-31 NI039951 core:CurrentFinancialInstruments core:WithinOneYear 2016-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: NI039951

Genomic Mining Limited

Annual Report and Financial Statements

for the Year Ended 31 March 2017

Chartered Accountants & Registered Auditors

 

Genomic Mining Limited

Profit and Loss Account for the Year Ended 31 March 2017

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

Genomic Mining Limited

(Registration number: NI039951)
Balance Sheet as at 31 March 2017

Note

2017
£

2016
£

Current assets

 

Debtors

3

4

4

Cash at bank and in hand

 

380

380

 

384

384

Creditors: Amounts falling due within one year

5

(15,774)

(15,774)

Net liabilities

 

(15,390)

(15,390)

Capital and reserves

 

Called up share capital

6

50,504

50,504

Profit and loss account

(65,894)

(65,894)

Total equity

 

(15,390)

(15,390)

For the financial year ending 31 March 2017 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 9 November 2017 and signed on its behalf by:
 

.........................................

Dr Paul Harkin

Director

 

Genomic Mining Limited

Notes to the Financial Statements for the Year Ended 31 March 2017

1

General information

The company is a private company limited by share capital incorporated in Northern Ireland.

The address of its registered office is:
126 Eglantine Avenue
Belfast
Co Antrim
BT9 6EU

These financial statements were authorised for issue by the Board on 9 November 2017.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Genomic Mining Limited

Notes to the Financial Statements for the Year Ended 31 March 2017

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Debtors

2017
£

2016
£

Other debtors

4

4

Total current trade and other debtors

4

4

4

Cash and cash equivalents

2017
£

2016
£

Cash at bank

380

380

5

Creditors

Note

2017
£

2016
£

Due within one year

 

Trade creditors

 

4,854

4,854

Accrued expenses

 

10,920

10,920

 

15,774

15,774

6

Share capital

Allotted, called up and fully paid shares

 

2017

2016

 

No.

£

No.

£

A Ordinary of £0.10 each

200,040

20,004.00

200,040

20,004.00

B Ordinary of £0.10 each

190,000

19,000.00

190,000

19,000.00

A Convertible cumulative redeemable preference of £1 each

11,500

11,500

11,500

11,500

 

401,540

50,504

401,540

50,504